APA (7th ed.) Citation

ML, G., SC, M., S, G., H, G., L, M., AD, S., . . . JJ, X. (2022). Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors. Cancer chemotherapy and pharmacology, 89(5), 671. https://doi.org/10.1007/s00280-022-04413-7

Chicago Style (17th ed.) Citation

ML, Green, Ma SC, Goble S, Giordano H, Maloney L, Simmons AD, Beltman J, Harding TC, and Xiao JJ. "Population Pharmacokinetics of Rucaparib in Patients with Advanced Ovarian Cancer or Other Solid Tumors." Cancer Chemotherapy and Pharmacology 89, no. 5 (2022): 671. https://doi.org/10.1007/s00280-022-04413-7.

MLA (9th ed.) Citation

ML, Green, et al. "Population Pharmacokinetics of Rucaparib in Patients with Advanced Ovarian Cancer or Other Solid Tumors." Cancer Chemotherapy and Pharmacology, vol. 89, no. 5, 2022, p. 671, https://doi.org/10.1007/s00280-022-04413-7.